Results 101 to 110 of about 2,382 (118)

Non-coding RNAs in Parkinson's Disease: Pathogenesis, Exosomes, and Therapeutic Horizons. [PDF]

Cell Mol Neurobiol
Rezaei N, Zivari Fard M, Kazemi M, Alani B, Noureddini M, Rafiyan M, Bahrami A, Yazdani MS, Eshraghi R, Mazoochi T, Mirzaei H.   +10 more
europepmc   +1 more source

Circular RNAs and endothelial dysfunction: mechanistic crosstalk and emerging therapeutic perspectives. [PDF]

Cell Mol Life Sci
Din ZU, Xia J, Wu ZG, Liao Z, Xiong XD.
europepmc   +1 more source

Epigenetic and Transcriptional Reprogramming in 3D Culture Models in Breast Cancer. [PDF]

Cancers (Basel)
Flores-García LC, Rubio K, Ibarra-Sierra E, Silva-Cázares MB, Palma-Flores C, López-Camarillo C.   +5 more
europepmc   +1 more source

Synovial Fluid and Serum MicroRNA Signatures in Equine Osteoarthritis. [PDF]

Int J Mol Sci
Castanheira CIGD, Taylor S, Skiöldebrand E, Rubio-Martinez LM, Hackl M, Clegg PD, Peffers MJ.   +6 more
europepmc   +1 more source

Emerging role of circular RNAs in diabetic retinopathy. [PDF]

Korean J Physiol Pharmacol
Kim H, Ryu J.
europepmc   +1 more source

Tumor exosomal miR-221-3p induces glycolysis through the LIFR/GLUT1 pathway to destroy the cerebral vascular endothelial cell barrier and promote breast cancer brain metastasis. [PDF]

J Transl Med
Zhu K, Yao H, Hei J, Li S, Ye T, Jiang W, Wang S, Luo Z, Martin T, Zhou J, Zhang S.   +10 more
europepmc   +1 more source

miR-615-3p Expression Level in Bone Marrow is Associated with Tumor Recurrence in Hepatocellular Carcinoma

miR-615-3p Expression Level in Bone Marrow is Associated with Tumor Recurrence in Hepatocellular Carcinoma
openaire